Artelo Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2015 | $-13.5K | $-13.5K | — | — |
| FY2016 | $-18.5K | $-18.5K | — | — |
| FY2017 | $-216.8K | $-216.8K | — | $3.3K |
| FY2018 | $-1.6M | $-1.6M | — | $290.0K |
| FY2019 | $-2.8M | $-2.8M | — | $425.1K |
| FY2020 | $-4.3M | $-4.3M | — | $381.0K |
| FY2021 | $-6.1M | $-6.1M | — | $1.5M |
| FY2022 | $-8.0M | $-8.0M | — | $2.5M |
| FY2023 | $-8.2M | $-8.2M | — | $1.0M |
| FY2024 | $-8.4M | $-8.4M | — | $818.0K |
| FY2025 | $-8.5M | $-8.5M | — | $1.1M |